Democrats and even some Republicans want to import Europe’s drug price controls. So it’s worth observing how Europe’s raid on drug makers to bolster its ailing national health systems is reducing pharmaceutical investment and access to treatments.

When I was a kid, my dad used to tell me there was nothing more important than health. Despite many colds, broken bones, and even when I was diagnosed with multiple sclerosis at 23, I couldn’t see why he stressed this point so vehemently.

Janice Dean from Fox News Radio sits down with Founder and Chairman of Survivors for Solutions John Czwartacki to discuss his battle with Multiple Sclerosis and the work he does to protect medical innovations that give people hope across the nation.

It’s time for everyone’s resolutions, personal and professional. At Survivors For Solutions, the new year means bringing about a new kind of advocacy by patients for patients…

It has been about four months since President Biden signed the Inflation Reduction Act (IRA) and, already, the law’s drug-pricing rules have dealt a major blow to medical innovation…

John Czwartacki’s resume is a laundry list of posts throughout pretty much every GOP political arena imaginable — he worked for former House Speaker John Boehner early in his career, as a spokesperson for former Senate Majority Leader Trent Lott, for FEMA in the Bush administration shortly after the 9/11 attacks, and for then-OMB Director Mick Mulvaney in the Trump White House — and now, he’s adding advocacy on drug pricing to his list…

Thirty years ago, as a congressional staffer, I never thought I would be diagnosed with a life-altering disease. I had every reason to be hopeful about my future. I was young, healthy, and solidly independent. Or so I thought…

WASHINGTON – Today, a new patient advocacy group led by multiple sclerosis survivor launched to promote and protect patients’ access to innovative treatments and therapies.

Remember John "Cz" Czwartacki? Worked on the Hill for big names like John Boehner, Bill Paxon and Trent Lott and then in the Trump administration under Mick Mulvaney? He also has MS, and he's launching a patient advocacy group.

It may take years before we can fully appreciate the impact of the Inflation Reduction Act on the pharmaceutical industry..